Does high dose therapy with autologous stem cell transplantation affect bone mineral density in patients with lymphoma?

被引：0
|
作者：
Fredriksson, R. [1 ]
Lewerin, C. [1 ]
Johansson, P. [1 ]
Mellstrom, D. [1 ]
Kristjansdottir, H. Lind [1 ]
机构：
[1] Univ Gothenburg, Gothenburg, Sweden
来源：
BONE MARROW TRANSPLANTATION | 2022年 / 57卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
P370
引用
收藏
页码：303 / 303
页数：1
相关论文
共 50 条
  • [1] High dose therapy and autologous stem cell transplantation in mantle cell lymphoma
    Hiddemann, W
    Dreyling, M
    Parwaresch, R
    Unterhalt, M
    ANNALS OF ONCOLOGY, 2005, 16 : 48 - 49
  • [2] Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation
    Seland, Mette
    Smeland, Knut B.
    Bjoro, Trine
    Falk, Ragnhild S.
    Fossa, Sophie D.
    Gjesdal, Clara G.
    Godang, Kristin
    Holte, Harald
    Svartberg, Johan
    Syversen, Unni
    Bollerslev, Jens
    Kiserud, Cecilie E.
    ACTA ONCOLOGICA, 2017, 56 (04) : 590 - 598
  • [3] High-dose therapy and autologous blood stem cell transplantation in patients with follicular lymphoma
    Voso, MT
    Martin, S
    Abdallah, A
    Hohaus, S
    Ho, AD
    Haas, R
    BONE MARROW TRANSPLANTATION, 1999, 23 : S10 - S10
  • [4] Bone mineral density of the left femoral neck in lymphoma survivors treated with high dose therapy with autologous stem cell support.
    Seland, Mette
    Smeland, Knut Halvor B.
    Holte, Harald
    Bjoero, Trine
    Godang, Kristin
    Bollerslev, Jens
    Fossa, Sophie D.
    Kiserud, Cecilie E.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [5] High dose therapy and autologous stem cell transplantation (ASCT) in ten patients with resistant cutaneous lymphoma
    Brice, P
    Marolleau, JP
    Cojean, I
    Baccard, M
    Devidas, A
    Baruchel, A
    Rybojad, M
    Hennequin, C
    Gisselbrecht, C
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 93 : 304 - 304
  • [6] Decreased bone mineral density after autologous stem cell transplantation
    Ria, R
    Scarponi, AM
    Falzetti, F
    Ballanti, S
    Di Ianni, M
    Cimminiello, M
    Gasbarrino, C
    Pallone, B
    Russo, F
    Cirulli, T
    Vacca, A
    Dammacco, F
    Mannarino, E
    Martelli, MF
    Tabilio, A
    BLOOD, 2003, 102 (11) : 981A - 981A
  • [7] High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma
    S Ingen-Housz-Oro
    H Bachelez
    O Verola
    C Lebbé
    J P Marolleau
    C Hennequin
    L Dubertret
    P Morel
    C Gisselbrecht
    P Brice
    Bone Marrow Transplantation, 2004, 33 : 629 - 634
  • [8] High-dose therapy and autologous stem cell transplantation in relapsing cutaneous lymphoma
    Ingen-Housz-Oro, S
    Bachelez, H
    Verola, O
    Lebbé, C
    Marolleau, JP
    Hennequin, C
    Dubertret, L
    Morel, P
    Gisselbrecht, C
    Brice, P
    BONE MARROW TRANSPLANTATION, 2004, 33 (06) : 629 - 634
  • [9] Chemotherapy with rituximab followed by high-dose therapy and autologous stem cell transplantation in patients with mantle cell lymphoma
    Thieblemont, C
    Antal, D
    Lacotte-Thierry, L
    Delwail, V
    Espinouse, D
    Michallet, AS
    Traulle, C
    Bouafia-Sauvy, F
    Giraud, C
    Salles, G
    Guilhot, F
    Coiffier, B
    CANCER, 2005, 104 (07) : 1434 - 1441
  • [10] HIGH-DOSE THERAPY AND AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION FOR PATIENTS WITH LYMPHOMA
    KESSINGER, A
    ARMITAGE, JO
    SMITH, DM
    LANDMARK, JD
    BIERMAN, PJ
    WEISENBURGER, DD
    BLOOD, 1989, 74 (04) : 1260 - 1265
12345